
Moving Real-World Evidence to Practice: Case-Based Applications of Anti-TNF Therapies in Rheumatoid Arthritis

Moving Real-World Evidence to Practice: Case-Based Applications of Anti-TNF Therapies in Rheumatoid Arthritis is organized by Prime Education, LLC.
Release Date: August 31, 2023
Expiration Date: August 30, 2024
Description:
New and emerging formulations and biosimilars of anti-TNF biologics will bring opportunities for treatment optimization while challenging providers to select among available options for inflammatory bowel disease (IBD). Tune in to this interactive video presentation in which experts in the field will review patient case scenarios and discuss anti-TNF therapy initiation and switching. Test your clinical competency through in-program polling and see how you stack up against your peers.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC program in Section 3 of the Royal College's MOC Program.
Learning Objectives:
• Apply guidelines, clinical evidence, and patient-centered factors to inform treatment decisions on initiating or switching anti-TNF therapies for RA
Agenda:
• Moderate-to-Severe RA: Selecting and Initiating Targeted Therapy
• To Switch or Not to Switch: Well-Controlled RA on Reference Adalimumab